Subir Kumar Das
About Subir Kumar Das
Data last updated:
Subir Kumar Das is a Director at Cadila Pharmaceuticals Limited (since 2025), Director at Transformers And Rectifiers (India) Limited (since 2018) and Director at Troikaa Pharmaceuticals Limited (since 2020), and holds 3 more current directorships. The companies operate in Pharma, Energy and Power and Engineering. The 6 current companies with reported revenue have a combined latest revenue of ₹8,160 Cr; the largest is Cadila Pharmaceuticals Limited at ₹3,869 Cr (FY 2025). Earlier, Subir Kumar Das was a Director at Dishman Carbogen Amcis Limited (2017–2024) and Nominee Director at Mitcon Consultancy & Engineering Services Limited (2007–2009) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cadila Pharmaceuticals Limited U24231GJ1991PLC015132 | Director | 30 Jun 2025 | 1991 | ₹3,869 Cr (FY 2025) | Active |
 Transformers And Rectifiers (India) Limited L33121GJ1994PLC022460 | Director | 14 Nov 2018 | 1994 | ₹2,051 Cr (FY 2025) | Active |
 Troikaa Pharmaceuticals Limited U24100GJ1994PLC022162 | Director | 03 Feb 2020 | 1994 | ₹1,088 Cr (FY 2025) | Active |
 M & B Engineering Limited L45200GJ1981PLC004437 | Director | 02 Apr 2024 | 1981 | ₹997 Cr (FY 2025) | Active |
 Irm Enterprises Private Limited U74110GJ2009PTC058116 | Director | 27 Jul 2020 | 2009 | ₹152 Cr (FY 2025) | Active |
 Troikaa Pharmachem Private Limited U24299GJ2021PTC127098 | Director | 08 Nov 2021 | 2021 | ₹2.57 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dishman Carbogen Amcis Limited L74900GJ2007PLC051338 | Director | 17 Mar 2017 | 2007 | ₹2,733 Cr (FY 2025) | Active |
 Mitcon Consultancy & Engineering Services Limited L74140PN1982PLC026933 | Nominee Director | 24 Sep 2007 | 1982 | ₹115 Cr (FY 2025) | Active |
 Baroda Asset Management India Limited U65991MH1992PLC069414 | Director | 09 May 2012 | 1992 | ₹43.30 Cr (FY 2021) | Amalgamated |
| Castings Dynamics Limited U40100MH1994PLC080707 | Director | 15 Dec 2014 | 1994 | ₹26.97 Cr (FY 2019) | Under Liquidation |
 Gujarat Industrial And Technical Consultancy Organisation Limited U91990GJ1978PLC003258 | Nominee Director | 30 Sep 2009 | 1978 | ₹6.03 Cr (FY 2024) | Active |
 The Nainital Bank Limited U65923UR1922PLC000234 | Director | 29 Dec 2009 | 1922 | ₹755 Cr (FY 2024) | Active |
 Hcp Plastene Bulkpack Limited L25200GJ1984PLC050560 | Director | 03 Feb 2021 | 1984 | ₹468 Cr (FY 2025) | Active |
 Irm Private Limited U74120GJ1994PTC023239 | Director | 04 Mar 2019 | 1994 | ₹307 Cr (FY 2025) | Active |
| Dishman Pharmaceuticals And Chemicals Limited L24230GJ1983PLC006329 | Director | 15 Dec 2014 | 1983 | ₹1,623 Cr (FY 2016) | Amalgamated |
| Sme Mavens Private Limited U85100GJ2015PTC081763 | Director | 19 Jun 2015 | 2015 | ₹2,460 (FY 2020) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subir Kumar Das
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subir Kumar Das
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subir Kumar Das
Subir Kumar Das currently holds 6 directorships: Cadila Pharmaceuticals Limited (Director, since 30 Jun 2025, revenue ₹3,869 Cr (FY 2025)); Transformers And Rectifiers (India) Limited (Director, since 14 Nov 2018, revenue ₹2,051 Cr (FY 2025)); Troikaa Pharmaceuticals Limited (Director, since 03 Feb 2020, revenue ₹1,088 Cr (FY 2025)); M & B Engineering Limited (Director, since 02 Apr 2024, revenue ₹997 Cr (FY 2025)); Irm Enterprises Private Limited (Director, since 27 Jul 2020, revenue ₹152 Cr (FY 2025)); and 1 more.
Subir Kumar Das was first appointed on 24 Sep 2007 as Nominee Director at Mitcon Consultancy & Engineering Services Limited. The most recent appointment on record is 30 Jun 2025 at Cadila Pharmaceuticals Limited.
The 6 current companies of Subir Kumar Das that report revenue have a combined latest revenue of ₹8,160 Cr: Cadila Pharmaceuticals Limited ₹3,869 Cr (FY 2025); Transformers And Rectifiers (India) Limited ₹2,051 Cr (FY 2025); Troikaa Pharmaceuticals Limited ₹1,088 Cr (FY 2025); M & B Engineering Limited ₹997 Cr (FY 2025); Irm Enterprises Private Limited ₹152 Cr (FY 2025); and 1 more.
Subir Kumar Das held 10 earlier board appointments: Dishman Carbogen Amcis Limited (Director, 17 Mar 2017 to 15 Dec 2024); Mitcon Consultancy & Engineering Services Limited (Nominee Director, 24 Sep 2007 to 22 Sep 2009); Baroda Asset Management India Limited (Director, 09 May 2012 to 01 Dec 2013); Castings Dynamics Limited (Director, 15 Dec 2014 to 18 Oct 2015); Gujarat Industrial And Technical Consultancy Organisation Limited (Nominee Director, 30 Sep 2009 to 29 Sep 2010); and 5 more.
The current boards of Subir Kumar Das's companies include Girdhar Prem Balwani (Cadila Pharmaceuticals Limited), Kamlesh Navaratnalal Shah (Cadila Pharmaceuticals Limited), Parul Nikunj Shah (Cadila Pharmaceuticals Limited), Rajiv Indravadan Modi (Cadila Pharmaceuticals Limited), Rajiv Rajiv Modi (Cadila Pharmaceuticals Limited), Ramesh Ratilal Choksi (Cadila Pharmaceuticals Limited), among others.